Decreased production of TNF and IL‐6 in whole blood of CLL patients
- 1 May 1995
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 49 (1) , 76-82
- https://doi.org/10.1002/ajh.2830490113
Abstract
Monocyte derived cytokines, tumor necrosis factor (TNF) and interleukin‐6 (IL‐6), were determined in cell free plasma after stimulation of heparinized whole blood from chronic lymphocytic leukemia (CLL) patients with lipopolysaccharide (LPS) at 1 μg/ml for 6 hr. Compared to control donors (390 U/ml), CLL patients in average had eight‐fold lower levels of TNF bioactivity (50 U/ml). The depressed levels were observed over a wide range of LPS concentrations (0.01 to 10 μg/ml). Furthermore, after stimulation with S. aureus bacteria, CLL samples gave three‐fold lower levels, as well. TNF levels were not decreased because of defective bioactivity of TNF, since strongly reduced levels of TNF protein were also detected in an immunoassay. Finally, interleukin‐6 levels after LPS stimulation were decreased threefold.Flow cytometry analysis with CD14 antibodies demonstrated comparable numbers of monocytes for control donors and CLL patients (698 ± 802 and 427 ± 267, respectively). This suggests that deficient cytokine production was not due to a reduction in monocyte number, but rather to a functional impairment.The deficiency in cytokine production observed after ex vivo stimulation of whole blood from CLL patients suggests that in vivo during bacterial infection, CLL patients will exhibit an inappropriate response as well. © 1995 witey‐Liss, Inc.Keywords
This publication has 27 references indexed in Scilit:
- Human b cells express membrane-bound and soluble forms of the cd 14 myeloid antigenMolecular Immunology, 1991
- Monoclonal antibodies to human tumor necrosis factor α: In vitro and in vivo applicationCytokine, 1990
- Deficient production of tumor necrosis factor by peripheral‐blood monocytes in chronic lymphocytic leukemiaInternational Journal of Cancer, 1990
- Zn++ inhibits both tumor necrosis factor‐mediated DNA fragmentation and cytolysisInternational Journal of Cancer, 1989
- TUMOUR NECROSIS FACTOR IN B CHRONIC LYMPHOCYTIC LEUKAEMIABritish Journal of Haematology, 1989
- Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working groupAmerican Journal of Hematology, 1988
- Secretory products of macrophages.Journal of Clinical Investigation, 1987
- Gangliosides in human chronic lymphocytic leukaemiaInternational Journal of Cancer, 1985
- Gangliosides of Human Chronic Lymphocytic Leukemia and Hairy CellsEuropean Journal of Biochemistry, 1983
- Immunological Deficiency Disorders Associated with Chronic Lymphocytic Leukemia and Multiple Myeloma*Journal of Clinical Investigation, 1964